Epigenetic mechanisms in memory formation

Nature Reviews Neuroscience

Volumn 6, Issue 2, 2005, Pages 108-118

  Levenson, Jonathan M ^a   Sweatt, J David ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; NUCLEAR PROTEIN;

CELL DIFFERENTIATION; CELL MATURATION; CHROMATIN STRUCTURE; EPIGENETICS; GENE EXPRESSION; HUMAN; MEMORY; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; COGNITION; COGNITION DISORDERS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; MEMORY; MODELS, MOLECULAR; NUCLEAR PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 13244276460     PISSN: 1471003X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrn1604     Document Type: Review

References (138)

1. Pray, L. Epigenetics: genome, meet your environment. Scientist 18, 14-20 (2004). This Is an excellent introduction to the field of epigenetics.
2. Si, K. et al. A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in Aplysia. Cell 115, 893-904 (2003). This study shows that the Aplysia form of the CPEB protein is necessary for the induction of long-term forms of synaptic plasticity.
3. Si, K., Lindquist, S. & Kandel, E. R. A neuronal isoform of the Aplysia CPEB has prion-like properties. Cell 115, 879-891 (2003). In this study, the authors provide evidence to indicate that the CPEB protein in Aplysia contains a prion-like domain that might act in an epigenetic-like manner to mark specific synapses for facilitation.
4. Egger, G., Liang, G., Aparicio, A. & Jones, P. A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-163 (2004).
5. Rakyan, V. K., Preis, J., Morgan, H. D. & Whitelaw, E. The marks, mechanisms and memory of epigenetic states in mammals. Biochem. J. 356, 1-10 (2001). This is an excellent recent review of epigenetic mechanisms.
6. Hatzis, P. & Talianidis, I. Regulatory mechanisms controlling human hepatocyte nuclear factor 4α gene expression. Mol. Cell Biol. 21, 7320-7330 (2001).
7. Crowe, A. J. et al. Hepatocyte nuclear factor 3 relieves chromatin-mediated repression of the α-fetoprotein gene. J. Biol. Chem. 274, 25113-25120 (1999).
8. Parrizas, M. et al. Hepatic nuclear factor 1-αα directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol. Cell. Biol. 21, 3234-3243 (2001).
9. Ehrenhofer-Murray, A. E. Chromatin dynamics at DNA replication, transcription and repair. Eur. J. Biochem. 271, 2335-2349 (2004).
10. Henderson, I. R., Shindo, C. & Dean, C. The need for winter in the switch to flowering. Annu. Rev. Genet. 37, 371-392 (2003).
11. Smale, S. T. The establishment and maintenance of lymphocyte identity through gene silencing. Nature Immunol. 4, 607-615 (2003).
12. Luger, K., Mader, A. W., Richmond, R. K., Sargent, D. F. & Richmond, T. J. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389, 251-260 (1997).
13. Strahl, B. D. & Allis, C. D. The language of covalent histone modifications. Nature 403, 41-45 (2000).
14. Tanner, K. G. et al. Catalytic mechanism and function of invariant glutamic acid 173 from the histone acetyltransferase GCN5 transcriptional co-activator. J. Biol. Chem. 274, 18157-18160 (1999).
15. Tanner, K. G., Langer, M. R., Kim, Y. & Denu, J. M. Kinetic mechanism of the histone acetyltransferase GCN5 from yeast. J. Biol. Chem. 275, 22048-22055 (2000).
16. Lau, O. D. et al. p300/CBP-associated factor histone acetyltransferase processing of a peptide substrate. Kinetic analysis of the catalytic mechanism. J. Biol. Chem. 275, 21953-21959 (2000).
17. Tanner, K. G., Langer, M. R. & Denu, J. M. Kinetic mechanism of human histone acetyltransferase P/CAF. Biochemistry 39, 11961-11969 (2000).
18. Murray, K. The occurrence of ε-N-methyl lysine in histones. Biochemistry 127, 10-15 (1964).
19. Goldknopf, I. L. et al. Isolation and characterization of protein A24, a 'histone-like' non-histone chromosomal protein. J. Biol. Chem. 250, 7182-7187 (1975).
20. Pickart, C. M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533 (2001).
21. Nickel, B. E. & Davie, J. R. Structure of polyubiquitinated histone H2A. Biochemistry 28, 964-968 (1989).
22. West, M. H. & Bonner, W. M. Histone 2B can be modified by the attachment of ubiquitin. Nucleic Acids Res. 8, 4671-4680 (1980).
23. Chen, H. Y., Sun, J. M., Zhang, Y., Davie, J. R. & Meistrich, M. L. Ubiquitination of histone H3 in elongating spermatids of rat testes. J. Biol. Chem. 273, 13165-13169 (1998).
24. Pham, A. D. & Sauer, F. Ubiquitin-activating/conjugating activity of TAFII250, a mediator of activation of gene expression in Drosophila. Science 289, 2357-2360 (2000).
25. Bradbury, E. M., Inglis, R. J., Matthews, H. R. & Sarner, N. Phosphorylation of very-lysine-rich histone in Physarum polycephalum. Correlation with chromosome condensation. Eur. J. Biochem. 33, 131-139 (1973).
26. Gurley, L. R., Waters, R. A. & Tobey, R. A. Cell cycle-specific changes in histone phosphorylation associated with cell proliferation and chromosome condensation. J. Cell Biol. 60, 356-364 (1974).
27. Mahadevan, L. C., Willis, A. C. & Barratt, M. J. Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell 65, 775-783 (1991).
28. Sassone-Corsi, P. et al. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3, Science 285, 886-891 (1999).
29. Thomson, S. et al. The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J. 18, 4779-4793 (1999).
30. Hsu, J. Y. et al. Mitotic phosphorylation of histone H3 is governed by lpl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 102, 279-291 (2000).
31. Di Agostino, S., Rossi, P., Geremia, R. & Sette, C. The MAPK pathway triggers activation of Nek2 during chromosome condensation in mouse spermatocytes. Development 129, 1715-1727 (2002).
32. Goto, H., Yasui, Y., Nigg, E. A. & Inagaki, M. Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation. Genes Cells 7, 11-17 (2002).
33. Ajiro, K., Yoda, K., Utsumi, K. & Nishikawa, Y. Alteration of cell cycle-dependent histone phosphorylations by okadaic acid. Induction of mitosis-specific H3 phosphorylation and chromatin condensation in mammalian interphase cells. J. Biol. Chem. 271, 13197-13201 (1996).
34. Nowak, S. J., Pai, C. Y. & Corces, V. G. Protein phosphatase 2A activity affects histone H3 phosphorylation and transcription in Drosophila melanogaster. Mol. Cell. Biol. 23, 6129-6138 (2003).
35. van Leeuwen, F., Gafken, P. R. & Gottschling, D. E. Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell 109, 745-756 (2002).
36. Brown, D. T. Histone H1 and the dynamic regulation of chromatin function. Biochem. Cell Biol. 81, 221-227 (2003).
37. Okano, M., Xie, S. & Li, E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet. 19, 219-220 (1998).
38. Chen, L. et al. Direct identification of the active-site nucleophile in a DNA (cytosine-5)-methyltransferase. Biochemistry 30, 11018-11025 (1991).
39. Bird, A. P. Use of restriction enzymes to study eukaryotic DNA methylation: II. The symmetry of methylated sites supports semi-conservative copying of the methylation pattern. J. Mol. Biol. 118, 49-60 (1978).
40. Cedar, H., Solage, A., Glaser, G. & Razin, A. Direct detection of methylated cytosine in DNA by use of the restriction enzyme Msp1. Nucleic Acids Res. 6, 2125-2132 (1979).
41. Cooper, D. N. & Krawczak, M. Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum. Genet. 83, 181-188 (1989).
42. Bird, A. P. CpG-rich islands and the function of DNA methylation. Nature 321, 209-213 (1986).
43. Maier, H., Colbert, J., Fitzsimmons, D., Clark, D. R. & Hagman, J. Activation of the early B-cell-specific mb-1 (lg-α) gene by Pax-5 is dependent on an unmethylated Ets binding site. Mol. Cell. Biol. 23, 1946-1960 (2003).
44. Bell, A. C. & Felsenfeld, G. Methylation of a CTCF-dependent boundary controls imprinted expression of the lgf2 gene. Nature 405, 482-485 (2000).
45. Hendrich, B. & Bird, A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18, 6538-6547 (1998).
46. Prokhortchouk, A. et al. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev. 15, 1613-1618 (2001).
47. Jones, P. L. et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genet. 19, 187-191 (1998).
48. Nan, X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389 (1998).
49. Montgomery, M. K., Xu, S. & Fire, A. RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 95, 15502-15507 (1998).
50. Volpe, T. A. et al. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 297, 1833-1837 (2002).
51. Hall, I. M. et al. Establishment and maintenance of a heterochromatin domain. Science 297, 2232-2237 (2002).
52. Verdel, A. et al. RNAi-mediated targeting of heterochromatin by the RITS complex. Science 303, 672-676 (2004).
53. Brown, C. J. & Chow, J. C. Beyond sense: the role of antisense RNA in controlling Xist expression. Semin. Cell Dev. Biol. 14, 341-347 (2003).
54. Chow, J. C. & Brown, C. J. Forming facultative heterochromatin: silencing of an X chromosome in mammalian females. Cell. Mol. Life Sci. 60, 2585-2603 (2003).
55. Sauman, I. & Reppert, S. M. Circadian dock neurons in the silkmoth Antheraea pemyi: novel mechanisms of Period protein regulation. Neuron 17, 889-900 (1996).
56. Crosthwaite, S. K. Circadian clocks and natural antisense RNA. FEBS Lett. 567, 49-54 (2004).
57. Ambros, V. The functions of animal microRNAs. Nature 431, 350-355 (2004).
58. Maue, R. A., Kraner, S. D., Goodman, R. H. & Mandel, G. Neuron-specific expression of the rat brain type II sodium channel gene is directed by upstream regulatory elements. Neuron 4, 223-231 (1990).
59. Li, L., Suzuki, T., Mori, N. & Greengard, P. Identification of a functional silencer element involved in neuron-specific expression of the synapsin I gene. Proc. Natl Acad. Sci. USA 90, 1460-1464 (1993).
60. + channel genes binds a factor present in nonneuronal cells but not in neuronal cells. Neuron 9, 45-54 (1992).
61. Chong, J, A. et al. REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 80, 949-957 (1995).
62. Chen, Z. F., Paquette, A. J. & Anderson, D. J. NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis. Nature Genet. 20, 136-142 (1998).
63. Paquette, A. J., Perez, S. E. & Anderson, D. J. Constitutive expression of the neuron-restrictive silencer factor (NRSF)/REST in differentiating neurons disrupts neuronal gene expression and causes axon pathfinding errors in vivo. Proc. Natl Acad. Sci. USA 97, 12318-12323 (2000).
64. Andres, M. E. et al. CoREST: a functional co-repressor required for regulation of neural-specific gene expression. Proc. Natl Acad. Sci. USA 96, 9873-9878 (1999).
65. Huang, Y., Myers, S. J. & Dingledine, R. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. Nature Neurosci. 2, 867-872 (1999).
66. Naruse, Y., Aoki, T., Kojima, T. & Mori, N. Neural restrictive silencer factor recruits mSin3 and histone deacetylase complex to repress neuron-specific target genes. Proc. Natl Acad. Sci. USA 96, 13691-13696 (1999).
67. Grimes, J. A. et al. The co-repressor mSin3A is a functional component of the REST-CoREST repressor complex. J. Biol. Chem. 275, 9461-9467 (2000).
68. Roopra, A. et al. Transcriptional repression by neuron-restrictive silencer factor is mediated via the Sin3-histone deacetylase complex. Mol. Cell. Biol. 20, 2147-2157 (2000).
69. Ballas, N. et al. Regulation of neuronal traits by a novel transcriptional complex. Neuron 31, 353-365 (2001).
70. Battaglioli, E. et al. REST repression of neuronal genes requires components of the hSWI.SNF complex. J. Biol. Chem. 277, 41038-41045 (2002).
71. Lunyak, V. V. et al. Co-repressor-dependent silencing of chromosomal regions encoding neuronal genes. Science 298, 1747-1752 (2002).
72. Reppert, S. M. & Weaver, D. R. Coordination of circadian timing in mammals. Nature 418, 935-941 (2002).
73. Klein, D. C., Moore, R. Y. & Reppert, S. M. Suprachiasmatic Nucleus: The Mind's Clock (Oxford Univ. Press, New York, 1991).
74. Zylka, M. J., Shearman, L. P., Weaver, D. R. & Reppert, S. M. Three period homologs in mammals: differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. Neuron 20, 1103-1110 (1998).
75. Balsalobre, A., Damiola, F. & Schibler, U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93, 929-937 (1998).
76. Naruse, Y. et al. Circadian and light-induced transcription of clock gene Per1 depends on histone acetylation and deacetylation. Mol. Cell. Biol. 24, 6278-6287 (2004).
77. Crosio, C., Cermakian, N., Allis, C. D. & Sassone-Corsi, P. Light induces chromatin modification in cells of the mammalian circadian clock. Nature Neurosci. 3, 1241-1247 (2000).
78. Morgan, J. I., Cohen, D. R., Hempstead, J. L. & Curran, T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237, 192-197 (1987).
79. Mugnaini, E., Berrebi, A. S., Morgan, J. I. & Curran, T. Fos-like immunoreactivity induced by seizure in mice is specifically associated with euchromatin in neurons. Eur. J. Neurosci. 1, 46-52 (1989).
80. Kokaia, M. et al. Suppressed epileptogenesis in BDNF mutant mice. Exp. Neurol. 133, 215-224 (1995).
81. Binder, D. K., Routbort, M. J., Ryan, T. E., Yancopoulos, G. D. & McNamara, J. O. Selective inhibition of kindling development by intraventricular administration of TrkB receptor body, J. Neurosci. 19, 1424-1436 (1999).
82. Grooms, S. Y., Opitz, T., Bennett, M. V. & Zukin, R. S. Status epilepticus decreases glutamate receptor 2 mRNA and protein expression in hippocampal pyramidal cells before neuronal death. Proc. Natl Acad. Sci. USA 97, 3631-3636 (2000).
83. Sanchez, R. M. et al. Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures. J. Neurosci. 21, 8154-8163 (2001).
84. Isackson, P. J., Huntsman, M. M., Murray, K. D. & Gall, C. M. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF Neuron 6, 937-948 (1991).
85. Emfors, P., Bengzon, J., Kokaia, Z., Persson, H. & Lindvall, O. Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron 7, 165-176 (1991).
86. Timmusk, T. et al. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10, 475-489 (1993).
87. Nibuya, M., Morinobu, S. & Duman, R. S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15, 7539-7547 (1995).
88. Huang, Y., Doherty, J. J. & Dingledine, R. Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus. J. Neurosci. 22, 8422-8428 (2002). Using the pilocarpine model for induction of status epilepticus, the authors show that acetylation of histone H4 is reduced at the promoter for GluR2, but increased at the promoter for the BDKF gene.
89. Tsankova, N. M., Kumar, A. & Nestler, E. J. Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J. Neurosci. 24, 5603-5610 (2004). This paper comprehensively screens the promoter regions of many genes for several types of modification to histones in the context of electroconvulsive shock.
90. Barondes, S. H. & Jarvik, M. E. The influence of actinomycin-D on brain RNA synthesis and on memory. J. Neurochem. 11, 187-195 (1964).
91. Cohen, H. D. & Barondes, S. H. Further studies of learning and memory after intracerebral actinomycin-D. J. Neurochem. 13, 207-211 (1966).
92. Flood, J. F., Bennett, E. L., Orme, E. & Rosenzweig, M. R. Relation of memory formation to controlled amounts of brain protein synthesis. Physiol. Behav. 15, 97-102 (1975).
93. Rood, J. F., Bennett, E. L., Orme, A. E. & Rosenzweig, M. R. Effects of protein synthesis inhibition on memory for active avoidance training. Physiol. Behav. 14, 177-184 (1975).
94. Squire, L. R., Emanuel, C. A., Davis, H. P. & Deutsch, J. A. Inhibitors of cerebral protein synthesis: association of aversive and amnesic effects. Behav. Biol. 14, 335-341 (1975).
95. Roberson, E. D. & Sweatt, J. D. A biochemical blueprint for long-term memory. Learn. Mem. 6, 381-388 (1999).
96. Selcher, J. C., Weeber, E. J., Varga, A. W., Sweatt, J. D. & Swank, M. Protein kinase signal transduction cascades in mammalian associative conditioning. Neuroscientist 8, 122-131 (2002).
97. Levenson, J. M. et al. A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-Rel. J. Neurosci. 24, 3933-3943 (2004).
98. Levenson, J. M. et al. Regulation of histone acetylation during memory formation in the hippocampus. J. Biol. Chem. 279, 40545-40559 (2004). This study shows that acetylation of H3 is increased by long-term memory formation and activation of the signalling pathways involved in memory formation, and shows that induction of LTP and formation of long-term memories can be enhanced by administration of HDAC inhibitors.
99. Phillips, R. G. & LeDoux, J. E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106, 274-285 (1992).
100. Kim, J. J., Rison, R. A. & Fanselow, M. S. Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fear. Behav. Neurosci. 107, 1093-1098 (1993).
101. Fanselow, M. S., Kim, J. J., Yipp, J. & De Oca, B. Differential effects of the N-methyl-D-aspartate antagonist DL-2-amino-5-phosphonovalerate on acquisition of fear of auditory and contextual cues. Behav. Neurosci. 108, 235-240 (1994).
102. Atkins, C. M., Selcher, J. C., Petraitis, J. J., Trzaskos, J. M. & Sweatt, J. D. The MAPK cascade is required for mammalian associative learning. Nature Neurosci. 1, 602-809 (1998).
103. Rampon, C. et al. Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice. Nature Neurosci. 3, 238-244 (2000).
104. Kalkhoven, E. CBP and p300: HATs for different occasions. Biochem. Pharmacol. 68, 1145-1155 (2004).
105. Dike, Y. et al. Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum. Mol. Genet. 8, 387-396 (1999).
106. Bourtchouladze, R. et al. A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4. Proc. Natl Acad. Sci. USA 100, 10518-10522 (2003).
107. Korzus, E., Rosenfeld, M. G. & Mayford, M. CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42, 961-972 (2004). Using an inducible, dominant-negative form of CBP, the authors show that derangement of CBP function leads to deficits in long-term memory formation and synaptic plasticity, and that these deficits can be rescued through the use of HDAC inhibitors.
108. +/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 42, 947-959 (2004). Modelling Rubinstein-Taybi syndrome through CBP haploinsufficiency, this study shows that loss of CBP function leads to deficits in memory formation, and that these deficits can be ameliorated through treatment with an HDAC inhibitor.
109. Yeh, S. H., Lin, C. H. & Gean, P. W. Acetylation of nuclear factor-κB in rat amygdala improves long-term but not short-term retention of fear memory. Mol. Pharmacol. 65, 1286-1292 (2004).
110. Malenka, R. C. & Bear, M. F. LTP and LTD; an embarrassment of riches. Neuron 44, 5-21 (2004).
111. Kiann, E., Antion, M. D., Banko, J. L. & Hou, L. Synaptic plasticity and translation initiation. Learn. Mem. 11, 365-372 (2004).
112. Pittenger, C. & Handel, E. R. In search of general mechanisms for long-lasting plasticity: Aplysia and the hippocampus. Philos. Trans. R. Soc. Lond. B 358, 757-763 (2003).
113. Guan, Z. et al. Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell 111, 483-493 (2002). This study shows that in Aplysia, treatments that induce synaptic facilitation lead to increases in histone acetylation and that treatments that induce synaptic depression lead to decreases in histone acetylation.
114. Harris, E. W., Ganong, A. H. & Cotman, C. W. Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors. Brain Res. 323, 132-137 (1984).
115. Morris, R. G., Anderson, E., Lynch, G. S. & Baudry, M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774-776 (1986).
116. English, J. D. & Sweatt, J. D. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J. Biol. Chem. 272, 19103-19106 (1997).
117. Crosio, C., Heitz, E., Allis, C. D., Borrelli, E. & Sassone-Corsi, P. Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons. J. Cell Sci. 116, 4905-4914 (2003).
118. Petrij, F. et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376, 348-351 (1995).
119. Blough, R. I. et al. Variation in microdeletions of the cyclic AMP-responsive element-binding protein gene at chromosome band 16p13.3 in the Rubinstein-Taybi syndrome. Am. J. Med. Genet. 90, 29-34 (2000).
120. Ellaway, C. & Christodoulou, J. Rett syndrome: clinical characteristics and recent genetic advances. Disabil. Rehabil. 23, 98-106 (2001).
121. Sirianni, N., Naidu, S., Pereira, J., Pillotto, R. F. & Hoffman, E. P. Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am. J. Hum. Genet. 63, 1552-1558 (1998).
122. Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet. 23, 185-188 (1999).
123. Collins, A. L. et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13, 2679-2689 (2004).
124. Turner, G., Webb, T., Wake, S. & Robinson, H. Prevalence of fragile X syndrome. Am. J. Med. Genet. 64, 196-197 (1996).
125. Ashley, C. T. et al. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nature Genet. 4, 244-251 (1993).
126. Gecz, J., Gedeon, A. K., Sutherland, G. R. & Mulley, J. C. Identification of the gene FMR2, associated with FRAXE mental retardation. Nature Genet. 13, 105-108 (1996).
127. Gu, Y., Shen, Y., Gibbs, R. A. & Nelson, D. L. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nature Genet. 13, 109-113 (1996).
128. Kuo, Y. M. et al. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077-4081 (1996).
129. Selkoe, D. J. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447-153 (1998).
130. Sastre, M. et al. Presenilin-dependent γ-secretase processing of β-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2, 835-841 (2001).
131. Kimberly, W. T., Zheng, J. B., Guenette, S. Y. & Selkoe, D. J. The intracellular domain of the β-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a Notch-like manner. J. Biol. Chem. 276, 40288-40292 (2001).
132. Cao, X. & Sudhof, T. C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120 (2001).
133. Von Rotz, R. C. et al. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J. Cell Sci. 117, 4435-4448 (2004).
134. Costa, E. et al. REELIN and schizophrenia: a disease at the interface of the genome and the epigenome. Mol. Intervent. 2, 47-57 (2002).
135. Chen, Y., Sharma, R. P., Costa, R. H., Costa, E. & Grayson, D. R. On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res. 30, 2930-2939 (2002).
136. Weaver, I. C. et al. Epigenetic programming by maternal behavior. Nature Neurosci. 7, 847-854 (2004). This study is one of the first to show that events in early postnatal development result in epigenetic tagging of the genome and can lead to long-term changes in behaviour.
137. Shahbazian, M. et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35, 243 (2002).
138. Zhao, X. et al. Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc. Natl Acad. Sci. USA 100, 6777-6782 (2003).